Bio Essence Corp 10-Q filing
Filed 2026-05-15 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001213900-26-057529
- Form type
- 10-Q
- CIK
- 0001723059
- Primary document
- https://www.sec.gov/Archives/edgar/data/1723059/000121390026057529/ea0290182-10q_bioessence.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Bio Essence Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $500,537 | - | - |
| Cost Of Revenue | $181,184 | - | - |
| Gross Profit | $319,353 | - | - |
| Operating Income | $215,795 | - | - |
| Net Income | $205,373 | - | - |
| Total Assets | $789,032 | - | - |
| Total Liabilities | $2.2M | - | - |
| Shareholders Equity | $-1.4M | - | - |
| Operating Cash Flow | $-411,970 | - | - |